LYMECYCLINE
Get in touch with us!
An overview
Limecycline is an antibiotic with bacteriostatic action that acts by inhibiting protein synthesis. It has a broad spectrum against Gram-positive and Gram-negative germs, especially Rickettsiae, Mycoplasma pneumoniae, Chlamydia sp, Vibrio Cholerae, Bacteroides sp, Brucella sp, etc. It is used in the treatment of:
• Otolaryngological and dental infections.
• Respiratory infections
• Urethritis (non-gonococcal)
• Gastrointestinal infections
• Genitourinary infections
• Skin and soft-tissue infections
• Brucellosis (associated with streptomycin)
• Typhoid typhus, psittacosis.
- Product Type: Tetracycline Antibiotic
- CAS Number: 992-21-2
- Common Indications: Treatment of moderate to severe acne
- Product Status: Commercial
- Available Grades: Non-Micronized
- Documentation: CEP, CoA, MSDS
Advantages
Efficacy:
Bacteriostatic action over a wide range of bacteria.
Good safety profile and well tolerated.
Optimal cost-efficiency across Europe.
Safety:
Rapidly and completely absorbed in the gastrointestinal tract.
Parenterally well-absorbed.
Finished
Dosage forms
Oral:
Capsule:
250 and 500 mg.
Global Market status
USD global market sales in 2021
consumed globally
Lorem ipsum solor
Few API manufacturers to cover worldwide demand.
Our API
Lymecycline
- Our API Limecycline is manufacture in accordance with cGMP and stringent international quality standards.
Quality
- Our quality control follows every stage from development of analytical methods to the control of manufacturing process.
Samples availables
PATENT PROTECTION
